Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$15,550,385
+$452,881 QoQ
Shares Held
99,224
+0.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
3.06%
of 13F equity value
Holder Rank
#133
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Fiduciary Investment Counsel, Inc. holds $51,339,791 across 7 Drug Manufacturers - General names. NVS ranks #2 (30.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
73,221 | $18,595,937 | |
| 2 | NVS |
Novartis AG
This page
|
99,224 | $15,550,385 | |
| 3 | AMGN |
Amgen Inc
|
25,171 | $9,114,922 | |
| 4 | PFE |
Pfizer Inc
|
256,357 | $6,173,076 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,118 | $914,663 | |
| 6 | LLY |
ELI LILLY & Co
|
435 | $521,752 | |
| 7 | ABBV |
AbbVie Inc.
|
1,864 | $469,056 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,550,385 | 99,224 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $15,097,504 | 98,838 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $18,674,215 | 135,448 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $17,500,912 | 136,470 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $16,556,951 | 136,823 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $15,202,304 | 136,368 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $13,827,361 | 142,096 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $16,154,674 | 140,451 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $15,071,755 | 141,572 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $13,645,120 | 141,064 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $14,540,083 | 144,004 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $14,844,159 | 145,731 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $15,224,392 | 150,871 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $14,194,956 | 154,293 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $14,369,775 | 158,397 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $12,220,811 | 160,779 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $13,665,542 | 161,665 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $14,862,305 | 169,371 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $14,889,405 | 170,223 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $13,688,172 | 167,378 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $15,449,486 | 169,328 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $14,841,977 | 173,631 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $18,573,719 | 196,693 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $16,785,106 | 193,021 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $16,327,339 | 186,940 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $15,470,340 | 187,633 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||